Montalescot G - Search Results

1

Summary of recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction.

Montalescot G, Andersen HR, Antoniucci D, Betriu A, de Boer MJ, Grip L, Neumann FJ, Rothman MT. Montalescot G, et al. Heart. 2004 Jun;90(6):676-7. doi: 10.1136/hrt.2003.016014. Heart. 2004. PMID: 15145878 Free PMC article. No abstract available.

2

IIb/IIIa inhibitors in acute myocardial infarction.

Montalescot G. Montalescot G. Blood Coagul Fibrinolysis. 1999 Feb;10 Suppl 1:S71-5. Blood Coagul Fibrinolysis. 1999. PMID: 10070824 Review.

3

Spontaneous late improvement of myocardial viability in the chronic infarct zone is possible, depending on persistent TIMI 3 flow and a low grade stenosis of the infarct artery.

Faraggi M, Montalescot G, Sarda L, Heintz JF, Doumit D, Drobinski G, Sotirov I, Le Guludec D, Thomas D. Faraggi M, et al. Among authors: montalescot g. Heart. 1999 Apr;81(4):424-30. doi: 10.1136/hrt.81.4.424. Heart. 1999. PMID: 10092571 Free PMC article.

4

Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention.

Collet JP, Montalescot G, Lesty C, Mishal Z, Soria J, Choussat R, Drobinski G, Soria C, Pinton P, Barragan P, Thomas D. Collet JP, et al. Among authors: montalescot g. Circulation. 2001 May 15;103(19):2328-31. doi: 10.1161/01.cir.103.19.2328. Circulation. 2001. PMID: 11352878 Clinical Trial.

5

Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.

Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, Boulenc JM, Morice MC, Maillard L, Pansiéri M, Choussat R, Pinton P; ADMIRAL Investigators. Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long-Term Follow-up. Montalescot G, et al. N Engl J Med. 2001 Jun 21;344(25):1895-903. doi: 10.1056/NEJM200106213442503. N Engl J Med. 2001. PMID: 11419426 Free article. Clinical Trial.

6

Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention.

Anderson KM, Califf RM, Stone GW, Neumann FJ, Montalescot G, Miller DP, Ferguson JJ 3rd, Willerson JT, Weisman HF, Topol EJ. Anderson KM, et al. Among authors: montalescot g. J Am Coll Cardiol. 2001 Jun 15;37(8):2059-65. doi: 10.1016/s0735-1097(01)01290-6. J Am Coll Cardiol. 2001. PMID: 11419888 Free article.

7

Transfer for primary angioplasty: who and how?

Dalby M, Montalescot G. Dalby M, et al. Among authors: montalescot g. Heart. 2002 Dec;88(6):570-2. doi: 10.1136/heart.88.6.570. Heart. 2002. PMID: 12433880 Free PMC article. Review.

8

[Non-ST acute coronary syndromes].

Collet JP, Choussat R, Montalescot G. Collet JP, et al. Among authors: montalescot g. Arch Mal Coeur Vaiss. 2002 Nov;95 Spec No 7:37-42. Arch Mal Coeur Vaiss. 2002. PMID: 12500603 Review. French.

9

[Medical treatment of acute coronary syndrome without ST-segment elevation].

Collet JP, Choussat R, Montalescot G. Collet JP, et al. Among authors: montalescot g. Rev Prat. 2003 Mar 15;53(6):624-8. Rev Prat. 2003. PMID: 12749148 Review. French.

10

Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality.

Collet JP, Montalescot G, Vicaut E, Ankri A, Walylo F, Lesty C, Choussat R, Beygui F, Borentain M, Vignolles N, Thomas D. Collet JP, et al. Among authors: montalescot g. Circulation. 2003 Jul 29;108(4):391-4. doi: 10.1161/01.CIR.0000083471.33820.3C. Epub 2003 Jul 14. Circulation. 2003. PMID: 12860898 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

813 results

Search Page

Filters